Loading...

KERALAYUR Kerala Ayurveda Ltd Capital Structure Changes Announcement

Krl

KRLY

Kerala Ayurveda Ltd

(KERALAYUR)

2023 Announcement

Show Summary

Show Summary

EGM Corrigendum

Acquisition Update

Annual Compliance Report

Financial Results Publication

Regulation 8(2) Disclosure

Share Encumbrance

Compliance Certificate

Management Change

Company Secretary Resignation

Resignation Notice

Financial Results Published

Strong Revenue Growth

Compliance Certificate

Board Meeting Cancelled

Office Address Change

Financial Results Published

Strong Revenue Growth

DSC Clarification

Regulatory Compliance

Directorate Changes

NCLT Order Notice

Director Retirements

Litigation Update

Annual Report Dispatch

AGM Announcement

Court Injunction Update

Financial Results Published

Strong Revenue Growth

Acquisition Announcement

Change in Designated Officer

Notice from Liquidator

Meeting Updates

Certificate Filing

Certificate Submission

Change in Directorate

Annual Secretarial Complian...

Financial Results Publication

Financial Results Publication

Financial Results Update

Compliance Assurance

Certificate Submission

Certificate Submission

Compliance Certificate

Financial Results Publication

Certificate U/R 74(5)

Equity Allotment

Trading Window Closing

Trading Plan Approval

Meeting Updates

Revenue increase

Certificate Submission

Management Appointment

AGM Notice Submission

Board Meeting Outcome

Financial Statements

Asset Acquisitions

Articles of Association

Financial Results Publication

Rights Offerings

Financial Results

Management Changes

Equity Offerings

External Links:

Data:

The trading window for purchasing, selling, or dealing in the shares of Kerala Ayurveda Ltd. will be closed from 31st December, 2023 until 48 hours after the announcement of the financial results of the company for the quarter ending 31st December, 2

AI Assistant

Kerala Ayurveda Ltd

2023

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.